Notable Analyst Rating Changes 4/9: ZZ, GTI, CNQ Upgraded; CRM, COCO, NKTR, MNKD Downgraded
More News related to CNQ
- BMO Upgrades Canadian Natural Resources (CNQ) to Outperform
- Credit Suisse Downgrades Canadian Natural Resources (CNQ) to Neutral
- Canadian Natural Resources Limited Announces Dividend
- Canadian Natural Resources Limited Announces Dividend
- Canadian Natural Resources Limited Announces 2009 First Quarter Results
More News related to COCO
- Apollo Group (APOL) Surges After Record Quarter, Boosts Sector
- RBC Capital Starts Coverage on 9 Education Stocks: Strayer (STRA) Named Top Pick
- Corinthian Colleges (COCO) Reports Solid Q3 Earnings; Guides Q4
- Education Stocks Getting Bullied Around on Credit Suisse Downgrades
- ITT Educational (ESI) Sinks After Disclosing Possibly Higher Default Rates
More News related to CRM
- Salesforce.com Receives 2009 Corporate Engagement Award of Excellence From Points of Light Institute
- CRH Medical introduces non surgical hemorroid removal to Gastroenterology Fellowship program
- ServoTerra Teams With Appirio and Salesforce.com to Build the First B2B Commodity and Futures Marketplace for Trading IT Assets
- Salesforce.com Executive Vice President Technology to Present at Wachovia Equity Conference
- Salesforce.com Chairman and CEO to Present at Structure 09
StreetInsider.com Notable Analyst Rating Changes:
UPGRADES:
Morgan Keegan upgrades Sealy Corp. (NYSE: ZZ) from Market Perform to Outperform.
Oppenheimer upgrades GrafTech International (NYSE: GTI) from Perform to Outperform, citing strong earnings and growth outlook. Price target $24.
Lehman Bros. upgrades Canadian Natural (NYSE: CNQ) from Equalweight to Overweight.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Bernstein downgrades Salesforce.com (NYSE: CRM) from Outperform to Market Perform.
Piper Jaffray downgrades Corinthian Colleges (Nasdaq: COCO) from Buy to Neutral and lowers its price target from $13 to $8.50.
Merrill Lynch downgrades Nektar (Nasdaq: NKTR) to Neutral and MannKind (Nasdaq: MNKD) to Sell, following Pfizer's (NYSE: PFE) cancer warning on inhaled insulin.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
HSBC initiates coverage on Vale (NYSE: RIO) with a Neutral. Price target $43.50.
Susquehanna initiates coverage on Deckers Outdoor (Nasdaq: DECK) with a Positive rating.
Wedbush Morgan initiates coverage on Intel (Nasdaq: INTC) with a Buy rating and $25 price target.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
-23.53
+18.37Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
